Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Int J Pharm ; 578: 119074, 2020 Mar 30.
Artigo em Inglês | MEDLINE | ID: mdl-31982561

RESUMO

Benzoyl peroxide (BPO) in the form of over the counter monotherapeutics or prescription-only combinations is a key component of topical acne therapy, but its unfavourable side effect profile reduces the therapeutic value of this compound. Various galenic approaches have been pursued to resolve this ambivalence, but only a few have managed to enter the market. This article aims to give a comprehensive overview of the published experimental vehicle systems and to identify the fundamental rationales. With regard to the formulation, an increase in the tolerability of BPO can essentially be achieved by combining BPO with re-fattening and moisturizing substances, by incorporating it and controlling its release, as well as by targeted deposition of the active ingredient at the site of action, i.e. drug targeting. Recently, novel particulate formulations have been proposed that combine several of these design principles and are expected to bring new developments in this dynamic field of research.


Assuntos
Acne Vulgar/tratamento farmacológico , Peróxido de Benzoíla , Fármacos Dermatológicos , Animais , Peróxido de Benzoíla/efeitos adversos , Peróxido de Benzoíla/química , Peróxido de Benzoíla/farmacologia , Peróxido de Benzoíla/uso terapêutico , Fármacos Dermatológicos/efeitos adversos , Fármacos Dermatológicos/química , Fármacos Dermatológicos/farmacologia , Fármacos Dermatológicos/uso terapêutico , Composição de Medicamentos , Humanos
2.
Int J Pharm ; 572: 118792, 2019 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-31676340

RESUMO

Benzoyl peroxide as a monotherapeutic and in combination with adapalene is a cornerstone of current acne therapy, but its unfavourable side effect profile reduces the therapeutic value of this compound. The incorporation into an adapalene-loaded microparticulate lipid matrix, which - via the principle of targeted erosion - allows the targeted release of active substances in the hair follicles, is a promising approach to reduce side effects such as skin redness, increased scaling and allergic reactions. However, there are challenges to the production of such a vehicle which require a galenic solution. That is in particular the redispersion of nanoparticulate benzoyl peroxide in lipids while maintaining its nanodisperse character. In the present work, the lamellar liquid crystalline phase of a binary water/phospholipid system is used to stabilize a nanosuspension during freeze-drying. Both after redispersing in water and after dispersing in nonpolar fat phases, the initial size of the nanosuspension was recovered with only minor deviations. The found cryoprotective effect of purified phospholipid allows the generation of highly concentrated solid-in-oil systems both in fat phases liquid at room temperature and in lipid melts, which after solidification can serve as starting material for the preparation of lipid microparticles loaded with benzoyl peroxide nanocrystals.


Assuntos
Combinação Adapaleno e Peróxido de Benzoil/química , Óleo de Coco/química , Fármacos Dermatológicos/química , Portadores de Fármacos , Nanopartículas , Fosfolipídeos/química , Triglicerídeos/química , Combinação Adapaleno e Peróxido de Benzoil/administração & dosagem , Combinação Adapaleno e Peróxido de Benzoil/metabolismo , Administração Cutânea , Animais , Cristalização , Fármacos Dermatológicos/administração & dosagem , Fármacos Dermatológicos/metabolismo , Composição de Medicamentos , Folículo Piloso/metabolismo , Nanotecnologia , Sus scrofa , Tecnologia Farmacêutica/métodos , Água/química
3.
Int J Pharm ; 564: 171-179, 2019 Jun 10.
Artigo em Inglês | MEDLINE | ID: mdl-30999051

RESUMO

Hair follicles are a promising target for the administration of drugs to treat diseases associated with the pilosebaceous unit, such as acne. For solid lipid microparticle dispersions a successful and selective delivery of adapalene via targeted erosion of the particles in sebum has been shown. By embedding nanoparticulate benzoyl peroxide in lipid microparticles, the therapeutic potency of adapalene can be further increased by improving follicular deposition of benzoyl peroxide and minimizing direct contact between benzoyl peroxide and stratum corneum, which is responsible for the irritating potential of this active agent. The aim of this study was to develop a novel nanoparticulate formulation for benzoyl peroxide suitable for the incorporation in solid lipid microparticles. In this contribution, a wet grinding process using liposomal dispersions of fully hydrated phosphatidylcholine was developed, upscaled and optimized for solid content and stabilizer concentration. The resulting novel nanosuspension was characterized by particle size and morphology and examined for chemical and physical stability as well as solubility and polymorphism. During the process development a dependency between the colloidal microstructure of the stabilizer dispersion and milling efficiency was found: while physical mixtures fail to deliver nanosuspensions, liposomal dispersions succeed with the same amount of stabilizer.


Assuntos
Adapaleno/química , Peróxido de Benzoíla/química , Nanopartículas/química , Estabilidade de Medicamentos , Liofilização , Lipossomos , Microscopia Eletrônica de Transmissão , Nanopartículas/ultraestrutura , Tamanho da Partícula , Solubilidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA